Implications of IPV introduction in national immunization schedule and strategies to combat shortages
Joint Event on 31st Euro Global Summit and Expo on Vaccines & Vaccination & 4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
June 14-16, 2018 Barcelona, Spain

Pragya Sharma, Rathi Akanksha, Taneja D K and Garg Suneela

Maulana Azad Medical College, India

Scientific Tracks Abstracts: J Vaccines Vaccin

Abstract:

With the upcoming globally synchronized switch from t OPV to b OPV for commitment of countries to be free from t OPV, 156 countries have pledged to stop using the same and replace it either with b OPV and IPV combination or only IPV. Thus there is humongous demand of IPV against the production capacity of the vaccine across the globe. There is an urgent need to explore various strategies to combat the forthcoming crisis in the given demand supply shortage and also in the post eradication era. Also it is important to consider the cost effective strategies for the middle and low income countries for sustainability once IPV has been included in the programme.

Biography :

Pragya Sharma has completed her MD in Public Health from Post Graduate Institute of Medical Sciences, Rohtak, India. After completing her education, she has served in Central Health Services, Government of India as Public Health Specialist heading the Reproductive and Child Health Programme for the National Capital Territory of Delhi, India for a period of three years. She is Professor in Community Medicine in Maulana Azad Medical College, a premier medical academic organization in the country. She has published more than 15 papers in reputed journals and has been serving as a reviewer member of repute.
Email:drpragyaS@gmail.com